{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T01:01:58Z","timestamp":1763600518770,"version":"3.45.0"},"reference-count":54,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","nmcd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nutrition, Metabolism and Cardiovascular Diseases"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.numecd.2025.104208","type":"journal-article","created":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T02:45:48Z","timestamp":1750733148000},"page":"104208","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Elevated serum parathyroid hormone predicts metabolic dysfunction-associated steatotic liver disease (MASLD) and progressive fibrosis"],"prefix":"10.1016","volume":"35","author":[{"given":"Chao","family":"Yan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaojie","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinzheng","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tongxu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinxin","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-3668-9946","authenticated-orcid":false,"given":"Xiaobing","family":"Gong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.numecd.2025.104208_bib1","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1097\/HEP.0000000000000520","article-title":"A multisociety Delphi consensus statement on new fatty liver disease nomenclature","volume":"78","author":"Rinella","year":"2023","journal-title":"Hepatology (Baltimore, Md)"},{"key":"10.1016\/j.numecd.2025.104208_bib2","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.jhep.2024.08.024","article-title":"Frailty and risk of metabolic dysfunction-associated steatotic liver disease and other chronic liver diseases","volume":"82","author":"Zhong","year":"2025","journal-title":"J Hepatol"},{"key":"10.1016\/j.numecd.2025.104208_bib3","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1186\/s12933-024-02434-5","article-title":"Metabolic dysfunction-associated steatotic liver disease and cardiovascular risk: a comprehensive review","volume":"23","author":"Zheng","year":"2024","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.numecd.2025.104208_bib4","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","article-title":"Mechanisms of NAFLD development and therapeutic strategies","volume":"24","author":"Friedman","year":"2018","journal-title":"Nat Med"},{"key":"10.1016\/j.numecd.2025.104208_bib5","doi-asserted-by":"crossref","DOI":"10.1038\/s41423-025-01307-5","article-title":"Immunopathogenic mechanisms and immunoregulatory therapies in MASLD","author":"He","year":"2025","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.numecd.2025.104208_bib6","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1001\/jama.2020.2298","article-title":"Nonalcoholic steatohepatitis: a review","volume":"323","author":"Sheka","year":"2020","journal-title":"Jama"},{"key":"10.1016\/j.numecd.2025.104208_bib7","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/hep.29466","article-title":"Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease","volume":"67","author":"Estes","year":"2018","journal-title":"Hepatology (Baltimore, Md)"},{"key":"10.1016\/j.numecd.2025.104208_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2021.154770","article-title":"Non-alcoholic fatty liver disease, insulin resistance, metabolic syndrome and their association with vascular risk","volume":"119","author":"Muzurovi\u0107","year":"2021","journal-title":"Metab, Clin Exp"},{"key":"10.1016\/j.numecd.2025.104208_bib9","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/S2468-1253(23)00066-3","article-title":"Non-invasive diagnosis and monitoring of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis","volume":"8","author":"Tincopa","year":"2023","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"10.1016\/j.numecd.2025.104208_bib10","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.jhep.2012.11.021","article-title":"Non-invasive diagnosis of non-alcoholic fatty liver disease. A critical appraisal","volume":"58","author":"Machado","year":"2013","journal-title":"J Hepatol"},{"key":"10.1016\/j.numecd.2025.104208_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2019.154005","article-title":"Non-invasive diagnosis of non-alcoholic steatohepatitis and fibrosis with the use of omics and supervised learning: a proof of concept study","volume":"101","author":"Perakakis","year":"2019","journal-title":"Metab, Clin Exp"},{"key":"10.1016\/j.numecd.2025.104208_bib12","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1152\/physrev.00031.2015","article-title":"Parathyroid hormone-related protein, its regulation of cartilage and bone development, and role in treating bone diseases","volume":"96","author":"Martin","year":"2016","journal-title":"Physiol Rev"},{"key":"10.1016\/j.numecd.2025.104208_bib13","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.cellsig.2015.12.012","article-title":"Parathyroid hormone induces adipocyte lipolysis via PKA-mediated phosphorylation of hormone-sensitive lipase","volume":"28","author":"Larsson","year":"2016","journal-title":"Cell Signal"},{"key":"10.1016\/j.numecd.2025.104208_bib14","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1475-2840-10-17","article-title":"Parathyroid hormone is a plausible mediator for the metabolic syndrome in the morbidly obese: a cross-sectional study","volume":"10","author":"R\u00f8islien","year":"2011","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.numecd.2025.104208_bib15","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1530\/EJE-09-0496","article-title":"Vitamin D, parathyroid hormone and the metabolic syndrome in middle-aged and older European men","volume":"161","author":"Lee","year":"2009","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.numecd.2025.104208_bib16","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.2337\/dc06-2438","article-title":"Vitamin D, parathyroid hormone levels, and the prevalence of metabolic syndrome in community-dwelling older adults","volume":"30","author":"Reis","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.numecd.2025.104208_bib17","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.atherosclerosis.2013.07.006","article-title":"Independent associations of low 25 hydroxy vitamin D and high parathyroid hormonal levels with nonalcoholic fatty liver disease in Asian Indians residing in north India","volume":"230","author":"Bhatt","year":"2013","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.numecd.2025.104208_bib18","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1007\/s40519-021-01151-2","article-title":"The predictive role of parathyroid hormone for non-alcoholic fatty liver disease based on invasive and non-invasive findings in candidates of bariatric surgery","volume":"27","author":"Jamialahmadi","year":"2022","journal-title":"Eat Weight Disord : EWD"},{"key":"10.1016\/j.numecd.2025.104208_bib19","doi-asserted-by":"crossref","DOI":"10.5812\/hepatmon.29697v2","article-title":"Parathyroid hormone levels may predict nonalcoholic steatohepatitis in morbidly obese patients","volume":"15","author":"Ghoghaei","year":"2015","journal-title":"Hepat Mon"},{"key":"10.1016\/j.numecd.2025.104208_bib20","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1007\/s11695-020-04453-z","article-title":"Determinants of high parathyroid hormone levels in patients with severe obesity and their relationship with the cardiometabolic risk factors, before and after a laparoscopic sleeve gastrectomy intervention","volume":"30","author":"Ministrini","year":"2020","journal-title":"Obes Surg"},{"key":"10.1016\/j.numecd.2025.104208_bib21","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1507\/endocrj.EJ20-0728","article-title":"Parathyroid hormone-related protein prevents high-fat-diet-induced obesity, hepatic steatosis and insulin resistance in mice","volume":"69","author":"Qin","year":"2022","journal-title":"Endocr J"},{"key":"10.1016\/j.numecd.2025.104208_bib22","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.899731","article-title":"Parathyroid hormone alleviates non-alcoholic liver steatosis via activating the hepatic cAMP\/PKA\/CREB pathway","volume":"13","author":"Feng","year":"2022","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.numecd.2025.104208_bib23","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1080\/21691401.2019.1615931","article-title":"Parathyroid hormone-related protein activates HSCs via hedgehog signalling during liver fibrosis development","volume":"47","author":"He","year":"2019","journal-title":"Artif Cell Nanomed Biotechnol"},{"key":"10.1016\/j.numecd.2025.104208_bib24","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1002\/hep.27368","article-title":"Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up","volume":"61","author":"Ekstedt","year":"2015","journal-title":"Hepatology (Baltimore, Md)"},{"key":"10.1016\/j.numecd.2025.104208_bib25","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.dld.2009.08.002","article-title":"Hepatic steatosis index: a simple screening tool reflecting nonalcoholic fatty liver disease","volume":"42","author":"Lee","year":"2010","journal-title":"Dig Liver Dis : Offic. J. Italian Soc. Gastroenterol Italian Assoc. Study Liver"},{"key":"10.1016\/j.numecd.2025.104208_bib26","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1471-230X-6-33","article-title":"The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population","volume":"6","author":"Bedogni","year":"2006","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.numecd.2025.104208_bib27","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s12986-022-00715-y","article-title":"Association between iron metabolism and non-alcoholic fatty liver disease: results from the National Health and Nutrition Examination Survey (NHANES 2017-2018) and a controlled animal study","volume":"19","author":"Zhang","year":"2022","journal-title":"Nutr Metabol"},{"key":"10.1016\/j.numecd.2025.104208_bib28","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1001\/jama.2023.17935","article-title":"Diagnosis and management of nonalcoholic fatty liver disease","volume":"330","author":"Leung","year":"2023","journal-title":"Jama"},{"key":"10.1016\/j.numecd.2025.104208_bib29","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1053\/j.gastro.2015.11.048","article-title":"Magnetic resonance imaging more accurately classifies steatosis and fibrosis in patients with nonalcoholic fatty liver disease than transient elastography","volume":"150","author":"Imajo","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.numecd.2025.104208_bib30","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1002\/hep.21496","article-title":"The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD","volume":"45","author":"Angulo","year":"2007","journal-title":"Hepatology (Baltimore, Md)"},{"key":"10.1016\/j.numecd.2025.104208_bib31","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1111\/jgh.14595","article-title":"HOMA-IR: an independent predictor of advanced liver fibrosis in nondiabetic non-alcoholic fatty liver disease","volume":"34","author":"Fujii","year":"2019","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.numecd.2025.104208_bib32","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.14309\/ajg.0000000000001166","article-title":"Heavy alcohol use is associated with gastric cancer: analysis of the national Health and nutrition examination survey from 1999 to 2010","volume":"116","author":"Laszkowska","year":"2021","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.numecd.2025.104208_bib33","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.metabol.2018.11.014","article-title":"Obesity and nonalcoholic fatty liver disease: from pathophysiology to therapeutics","volume":"92","author":"Polyzos","year":"2019","journal-title":"Metab, Clin Exp"},{"key":"10.1016\/j.numecd.2025.104208_bib34","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1002\/hep.25772","article-title":"Association between diabetes, family history of diabetes, and risk of nonalcoholic steatohepatitis and fibrosis","volume":"56","author":"Loomba","year":"2012","journal-title":"Hepatology (Baltimore, Md)"},{"key":"10.1016\/j.numecd.2025.104208_bib35","doi-asserted-by":"crossref","DOI":"10.3390\/biom10121702","article-title":"Oxidative stress in NAFLD: role of nutrients and food contaminants","volume":"10","author":"Rives","year":"2020","journal-title":"Biomolecules"},{"key":"10.1016\/j.numecd.2025.104208_bib36","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/ajg.2009.587","article-title":"Predicting fibrosis worsening in obese patients with NASH through parenchymal fibronectin, HOMA-IR, and hypertension","volume":"105","author":"Sorrentino","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.numecd.2025.104208_bib37","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1111\/imj.14709","article-title":"Non-alcoholic fatty liver disease: a review of epidemiology, risk factors, diagnosis and management","volume":"50","author":"Huang","year":"2020","journal-title":"Intern Med J"},{"key":"10.1016\/j.numecd.2025.104208_bib38","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1242\/dmm.001180","article-title":"A comprehensive definition for metabolic syndrome","volume":"2","author":"Huang","year":"2009","journal-title":"Dis Model Mech"},{"key":"10.1016\/j.numecd.2025.104208_bib39","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1530\/EJE-08-0072","article-title":"Relation of 25-hydroxyvitamin D and parathyroid hormone levels with metabolic syndrome among US adults","volume":"159","author":"Reis","year":"2008","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.numecd.2025.104208_bib40","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1475-2840-8-7","article-title":"Parathyroid hormone, but not vitamin D, is associated with the metabolic syndrome in morbidly obese women and men: a cross-sectional study","volume":"8","author":"Hjelmesaeth","year":"2009","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.numecd.2025.104208_bib41","first-page":"1065","article-title":"Parathyroid diseases and metabolic syndrome","volume":"46","author":"Modica","year":"2023","journal-title":"J Endocrinol Investig"},{"key":"10.1016\/j.numecd.2025.104208_bib42","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1093\/cvr\/cvs092","article-title":"Aldosterone and parathyroid hormone: a precarious couple for cardiovascular disease","volume":"94","author":"Tomaschitz","year":"2012","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.numecd.2025.104208_bib43","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.ijcard.2016.11.080","article-title":"Primary hyperparathyroidism predicts hypertension: results from the national inpatient sample","volume":"227","author":"Kalla","year":"2017","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.numecd.2025.104208_bib44","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S0306-9877(03)00227-5","article-title":"PTH excess may promote weight gain by impeding catecholamine-induced lipolysis-implications for the impact of calcium, vitamin D, and alcohol on body weight","volume":"61","author":"McCarty","year":"2003","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.numecd.2025.104208_bib45","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1097\/MEG.0000000000001486","article-title":"Association of serum vitamin D level and nonalcoholic fatty liver disease: a meta-analysis","volume":"32","author":"Liu","year":"2020","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.numecd.2025.104208_bib46","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.cgh.2022.01.021","article-title":"Inverse association between serum 25-hydroxyvitamin D and nonalcoholic fatty liver disease","volume":"21","author":"Yuan","year":"2023","journal-title":"Clin Gastroenterol Hepatol : Offic Clin Practice J Am Gastroenterol Assoc"},{"key":"10.1016\/j.numecd.2025.104208_bib47","doi-asserted-by":"crossref","DOI":"10.3390\/ijms242015485","article-title":"The role of vitamin D and its molecular bases in insulin resistance, diabetes, metabolic syndrome, and cardiovascular disease: state of the art","volume":"24","author":"Argano","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.numecd.2025.104208_bib48","article-title":"Serum vitamin D levels in relation to metabolic syndrome: a systematic review and dose-response meta-analysis of epidemiologic studies","volume":"22","author":"Hajhashemy","year":"2021","journal-title":"Obes Rev : an official journal of the International Association for the Study of Obesity"},{"key":"10.1016\/j.numecd.2025.104208_bib49","doi-asserted-by":"crossref","DOI":"10.3390\/nu10040496","article-title":"Vitamin D and the liver-correlation or cause?","volume":"10","author":"Keane","year":"2018","journal-title":"Nutrients"},{"key":"10.1016\/j.numecd.2025.104208_bib50","doi-asserted-by":"crossref","DOI":"10.3390\/nu12072097","article-title":"Immunologic effects of vitamin D on human Health and disease","volume":"12","author":"Charoenngam","year":"2020","journal-title":"Nutrients"},{"key":"10.1016\/j.numecd.2025.104208_bib51","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25094901","article-title":"Vitamin D and metabolic dysfunction-associated steatotic liver disease (MASLD): novel mechanistic insights","volume":"25","author":"Aggeletopoulou","year":"2024","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.numecd.2025.104208_bib52","doi-asserted-by":"crossref","first-page":"479","DOI":"10.3390\/ijms17040479","article-title":"Different serum free fatty acid profiles in NAFLD subjects and healthy controls after oral fat load","volume":"17","author":"Gambino","year":"2016","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.numecd.2025.104208_bib53","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1002\/hep.25539","article-title":"Effect of adipose tissue insulin resistance on metabolic parameters and liver histology in obese patients with nonalcoholic fatty liver disease","volume":"55","author":"Lomonaco","year":"2012","journal-title":"Hepatology (Baltimore, Md)"},{"key":"10.1016\/j.numecd.2025.104208_bib54","doi-asserted-by":"crossref","DOI":"10.1002\/dmrr.3570","article-title":"A novel model for detecting advanced fibrosis in patients with nonalcoholic fatty liver disease","volume":"38","author":"Yang","year":"2022","journal-title":"Diabetes\/Metabol Res Rev"}],"container-title":["Nutrition, Metabolism and Cardiovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S093947532500362X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S093947532500362X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T00:57:45Z","timestamp":1763600265000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S093947532500362X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":54,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S093947532500362X"],"URL":"https:\/\/doi.org\/10.1016\/j.numecd.2025.104208","relation":{},"ISSN":["0939-4753"],"issn-type":[{"type":"print","value":"0939-4753"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Elevated serum parathyroid hormone predicts metabolic dysfunction-associated steatotic liver disease (MASLD) and progressive fibrosis","name":"articletitle","label":"Article Title"},{"value":"Nutrition, Metabolism and Cardiovascular Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.numecd.2025.104208","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Italian Diabetes Society, the Italian Society for the Study of Atherosclerosis, the Italian Society of Human Nutrition and the Department of Clinical Medicine and Surgery, Federico II University. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104208"}}